Devices › Device types
FDA product code KSZ · class 2 · Hematology
System, test, automated blood grouping and antibody: medical device reports filed with FDA
10,406 reports carry this product code, 1994–2026; 13 brands with a page.
- 10,406
- reports with this product code
- 0% of all MAUDE reports
- 50
- reports, 12 months to August 2026
- 74 in the 12 months before
- 96.2%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
Product code KSZ is FDA's classification for "System, test, automated blood grouping and antibody" (hematology panel), a class 2 device. 10,406 medical device reports carry this product code, 0% of the MAUDE database, from March 1994 to August 2026.
50 reports arrived in the 12 months to August 2026, down 32% from 74 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.2%), other (2.5%) and injury (1%). 13 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Ortho Provue | 1,437 | 0 | 0% | 97.3% |
| Galileo Echo | 896 | 0 | 0% | 100% |
| Galileo | 660 | 0 | 0.1% | 97.6% |
| Capture-R Ready-Screen 3 | 491 | 0 | 0% | 100% |
| 0 8% Resolve Panel A | 373 | 0 | 0% | 88.5% |
| Ortho Provue Analyzer | 332 | 0 | 0% | 97.7% |
| Echo | 249 | 0 | 0% | 100% |
| Galileo Neo | 177 | 0 | 0% | 100% |
| 0 8% Surgiscreen | 157 | 0 | 0% | 71.7% |
| Tango Optimo | 156 | 0 | 0% | 100% |
| 0 8% Selectogen | 151 | 0 | 0% | 83.1% |
| Mts A/B/D Monoclonal And Reverse Grouping Card | 144 | 0 | 0% | 98.4% |
| Ortho Summit Sample Handling System | 1 | 0 | 0% | 69.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Immucor | 3,926 | 37.7% |
| Micro Typing Systems | 1,468 | 14.1% |
| Bio-Rad Medical Diagnostics | 1,083 | 10.4% |
| Ortho-Clinical Diagnostics | 1,080 | 10.4% |
| Ortho Clinical Diagnostics | 1,072 | 10.3% |
| Microtyping Systems | 1,014 | 9.7% |
| Olympus Optical | 8 | 0.1% |
| Beckman Coulter | 2 | 0% |
| Hamilton Bonaduz | 1 | 0% |
| Nellcor Puritan Bennett | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| False negative result | 5,504 | 52.9% |
| Incorrect or inadequate test results | 1,358 | 13.1% |
| False positive result | 1,128 | 10.8% |
| Incorrect, inadequate or imprecise result or readings | 542 | 5.2% |
| Fluid/blood leak | 422 | 4.1% |
| Other (for use when an appropriate device code cannot be identified) | 329 | 3.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 211 | 2% |
| Display difficult to read | 105 | 1% |
| Defective devicethe device was defective | 100 | 1% |
| Improper or incorrect procedure or method | 85 | 0.8% |
| Device issuea problem with the device | 74 | 0.7% |
| Leak/splashthe device leaked | 73 | 0.7% |
| Unexpected therapeutic results | 72 | 0.7% |
| Overfill | 70 | 0.7% |
| Bent | 61 | 0.6% |
| Malfunction | 61 | 0.6% |
| Contamination | 58 | 0.6% |
| Device displays incorrect message | 58 | 0.6% |
| Defective component | 56 | 0.5% |
| False reading from device non-compliance | 56 | 0.5% |
Questions about system, test, automated blood grouping and antibody reports
What is product code KSZ?
FDA's classification code for "System, test, automated blood grouping and antibody", class 2, reviewed by the hematology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
10,406 reports through August 2026, 50 of them in the latest 12 months.
Which brands appear most often?
Ortho Provue (1,437), Galileo Echo (896), Galileo (660), Capture-R Ready-Screen 3 (491) and 0 8% Resolve Panel A (373). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.